Annual Current Liabilities
$247.59 M
+$79.98 M+47.72%
December 31, 2023
Summary
- As of February 12, 2025, APLS annual total current liabilities is $247.59 million, with the most recent change of +$79.98 million (+47.72%) on December 31, 2023.
- During the last 3 years, APLS annual current liabilities has risen by +$119.27 million (+92.94%).
- APLS annual current liabilities is now at all-time high.
Performance
APLS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$191.26 M
+$22.09 M+13.06%
September 30, 2024
Summary
- As of February 12, 2025, APLS quarterly total current liabilities is $191.26 million, with the most recent change of +$22.09 million (+13.06%) on September 30, 2024.
- Over the past year, APLS quarterly current liabilities has dropped by -$56.33 million (-22.75%).
- APLS quarterly current liabilities is now -22.75% below its all-time high of $247.59 million, reached on December 31, 2023.
Performance
APLS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
APLS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +47.7% | -22.8% |
| 3 y3 years | +92.9% | +45.1% |
| 5 y5 years | +1354.3% | +45.1% |
APLS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +87.8% | -22.8% | +65.7% |
| 5 y | 5-year | at high | +276.6% | -22.8% | +276.9% |
| alltime | all time | at high | >+9999.0% | -22.8% | >+9999.0% |
Apellis Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $191.26 M(+13.1%) |
| Jun 2024 | - | $169.17 M(-21.4%) |
| Mar 2024 | - | $215.29 M(-13.0%) |
| Dec 2023 | $247.59 M(+47.7%) | $247.59 M(+33.4%) |
| Sep 2023 | - | $185.63 M(+6.2%) |
| Jun 2023 | - | $174.84 M(+26.1%) |
| Mar 2023 | - | $138.64 M(-17.3%) |
| Dec 2022 | $167.61 M(+27.1%) | $167.61 M(+45.2%) |
| Sep 2022 | - | $115.45 M(-8.9%) |
| Jun 2022 | - | $126.79 M(+1.6%) |
| Mar 2022 | - | $124.77 M(-5.4%) |
| Dec 2021 | $131.85 M(+2.7%) | $131.85 M(+39.9%) |
| Sep 2021 | - | $94.24 M(-40.3%) |
| Jun 2021 | - | $157.79 M(+88.6%) |
| Mar 2021 | - | $83.67 M(-34.8%) |
| Dec 2020 | $128.33 M | $128.33 M(+70.5%) |
| Sep 2020 | - | $75.27 M(+29.8%) |
| Jun 2020 | - | $57.99 M(+14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $50.74 M(-22.8%) |
| Dec 2019 | $65.75 M(+286.2%) | $65.75 M(+47.5%) |
| Sep 2019 | - | $44.57 M(+25.2%) |
| Jun 2019 | - | $35.59 M(+74.6%) |
| Mar 2019 | - | $20.39 M(+19.7%) |
| Dec 2018 | $17.02 M(+159.8%) | $17.02 M(+6.2%) |
| Sep 2018 | - | $16.03 M(+56.4%) |
| Jun 2018 | - | $10.25 M(+40.6%) |
| Mar 2018 | - | $7.29 M(+11.3%) |
| Dec 2017 | $6.55 M(+80.1%) | $6.55 M(-5.5%) |
| Sep 2017 | - | $6.94 M(+13.4%) |
| Jun 2017 | - | $6.12 M(+68.1%) |
| Dec 2016 | $3.64 M(+13.7%) | $3.64 M(+13.7%) |
| Dec 2015 | $3.20 M(+195.9%) | $3.20 M(+20.5%) |
| Sep 2015 | - | $2.66 M(+109.0%) |
| Jun 2015 | - | $1.27 M(+17.5%) |
| Dec 2014 | $1.08 M(+59.7%) | $1.08 M |
| Dec 2013 | $677.00 K | - |
FAQ
- What is Apellis Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual current liabilities year-on-year change?
- What is Apellis Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly current liabilities year-on-year change?
What is Apellis Pharmaceuticals annual total current liabilities?
The current annual current liabilities of APLS is $247.59 M
What is the all time high annual current liabilities for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual total current liabilities is $247.59 M
What is Apellis Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, APLS annual total current liabilities has changed by +$79.98 M (+47.72%)
What is Apellis Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of APLS is $191.26 M
What is the all time high quarterly current liabilities for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly total current liabilities is $247.59 M
What is Apellis Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, APLS quarterly total current liabilities has changed by -$56.33 M (-22.75%)